| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446425A2 Treatment of micro-organism infection |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446416A1 Tumor specific monoclonal antibodies |
| 08/18/2004 | EP1446415A2 Detection and identification of enteric bacteria |
| 08/18/2004 | EP1446157A2 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 08/18/2004 | EP1446156A2 Method to obtain protection against bystander allergen |
| 08/18/2004 | EP1446152A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors |
| 08/18/2004 | EP1305625A4 Method for immuno-detection of epitopes |
| 08/18/2004 | EP1073671A4 Targeted gene delivery to cells by filamentous bacteriophage |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0954330A4 Intestinal trefoil proteins |
| 08/18/2004 | EP0877622B1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522516A Secure header information for multi-content e-mail |
| 08/18/2004 | CN1522264A 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 08/18/2004 | CN1522156A Novel engineered superantigen for human therapy |
| 08/18/2004 | CN1522155A Method for producing a vaccine |
| 08/18/2004 | CN1520885A Room temperature storable immunoglobulin preparation for intravenous injection |
| 08/18/2004 | CN1162543C Gene encoding sulfotransferase |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/17/2004 | US6777540 Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligand |
| 08/17/2004 | US6777538 Binding protein |
| 08/17/2004 | US6777222 Antibodies to cryptosporidium |
| 08/17/2004 | US6777204 Receptor protein and method for diagnosing inflammatory diseases by using the same |
| 08/17/2004 | US6777194 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 08/17/2004 | US6777178 Antibodies for judging possibility of the onset of bovine leukemia |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/12/2004 | WO2004068139A2 Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes |
| 08/12/2004 | WO2004068135A2 Identification and modification of immunodominant epitopes in polypeptides |
| 08/12/2004 | WO2004068115A2 Assay method for group transfer reactions |
| 08/12/2004 | WO2004067743A1 Vaccine production using transposon based vectors |
| 08/12/2004 | WO2004067741A1 Transcriptional activator |
| 08/12/2004 | WO2004067718A2 Necrosis-deficient mutants of tuberculosis bacteria |
| 08/12/2004 | WO2004067707A2 Administration of transposon-based vectors to reproductive organs |
| 08/12/2004 | WO2004067706A2 Production of multimeric proteins |
| 08/12/2004 | WO2004067571A1 Monoclonal antibody against human hepatoma and use thereof |
| 08/12/2004 | WO2004067570A2 Prostate cancer diagnosis and treatment |
| 08/12/2004 | WO2004067569A1 Internalising human binding molecules against cd72 |
| 08/12/2004 | WO2004067568A2 Human il-1 beta antagonists |
| 08/12/2004 | WO2004067567A2 Anti-dengue virus antibodies, compositions, methods and uses |
| 08/12/2004 | WO2004067561A1 Amyloid-$g(b)(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 08/12/2004 | WO2004067559A1 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria |
| 08/12/2004 | WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | WO2004067553A2 Tolerance-induced targeted antibody production |
| 08/12/2004 | WO2004067038A1 Anthracycline-antibody conjugates |
| 08/12/2004 | WO2004067035A1 Use of avian antibodies |
| 08/12/2004 | WO2004067034A1 Use of anti-cd100 antibodies |
| 08/12/2004 | WO2004066957A2 ANTI-INTEGRIN ανβ3 ANTIBODY FORMULATIONS AND USES THEREOF |
| 08/12/2004 | WO2004066956A2 Uses of integrin alphavbeta3 antagonists |
| 08/12/2004 | WO2004066948A2 Mapcaxs as modifiers of the apc and axin pathways and methods of use |
| 08/12/2004 | WO2004066937A2 Antibodies specific for plasmacytoid dendritic cells |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004066917A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 08/12/2004 | WO2004066914A2 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | WO2004055494A3 Compositions and methods for detecting animal by product in feed |
| 08/12/2004 | WO2004050901A3 Method for the selection of cells producing specifically binding molecules |
| 08/12/2004 | WO2004046187A3 Antibodies for in vitro use |
| 08/12/2004 | WO2004043563A3 Methods of isolation of active compounds and activated targets |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004039845A8 Antimicrobial lipase antibodies their nucleotide and aminoacid sequences and uses thereof |
| 08/12/2004 | WO2004035608A3 System and method for cleaving antibodies |
| 08/12/2004 | WO2004035607A3 Human monoclonal antibodies against cd20 |
| 08/12/2004 | WO2004026250A3 Re-activated t-cells for adoptive immunotherapy |
| 08/12/2004 | WO2004016222A3 Hepatitis c viral-like particle purification |
| 08/12/2004 | WO2004011611A3 Taci antibodies and uses thereof |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003048337A3 Antibody to latent membrane proteins and uses thereof |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002077179A8 Leinamycin biosynthesis gene cluster and its components and their uses |
| 08/12/2004 | WO2002059299A9 Expression cloning method |
| 08/12/2004 | US20040158880 Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157779 Prevention and treatment of amyloidogenic disease |
| 08/12/2004 | US20040157330 Compositions and methods for targeted biological delivery of molecular carriers |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157291 expressed sequence tag (EST); of fusion proteins comprising the first N-terminal domain of the geneIII protein of filamentous phage as fusion partner for the expression of a fused (poly)peptide/protein |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157241 Haemophilus adherence and penetration proteins |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157227 uses detection of relatively increased levels of ghrelin, an exon 3-deleted form of preproghrelin and/or growth hormone secretagogue type 1b receptor expression |
| 08/12/2004 | US20040157215 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 08/12/2004 | US20040157214 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 08/12/2004 | US20040157210 Novel method for cloning variable domain sequences of immunological gene repertoire |
| 08/12/2004 | US20040156861 elicit native epitope-reactive Cm; may contribute to the development of CTL-epitope based vaccines in viral disease and cancer. |
| 08/12/2004 | US20040156856 adding a labeled antibody, which binds to the autoinducer having a homoserine lactone ring with an N-acyl side chain, to a lysine-containing protein, and detection of immunospecific binding; N-(3-oxododecanoyl)-L-homoserine lactone |
| 08/12/2004 | US20040156853 contacting cells undergoing uncontrolled growth with an antibody to RLIP76; may be used with chemootherapy or radiotherapy |
| 08/12/2004 | US20040156850 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 08/12/2004 | US20040156849 inhibiting interleukin-17 production by T cells by treating the cells with an antagonist of interleukin-23; also induction of IL-7 production by using an IL-23 agonist; identifying an anti-inflammatory agent c |
| 08/12/2004 | US20040156848 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 08/12/2004 | US20040156847 Remedies for eosinophilic diseases |
| 08/12/2004 | US20040156846 administering energy from an energy source such as alternating magnetic field, microwaves or sound waves to a bioprobe that comprises a susceptor and a chimeric L6 antibody to effect targeted hyperthermia therapy |
| 08/12/2004 | US20040156843 peptides containing specific amino acid sequences or antibodies that bind to cell membrane antigens on the surface of rapidly dividing endothelial cells; polynucleotide molecule encoding a heavy chain variable domain of antibody B2G4, |
| 08/12/2004 | US20040156841 Human amine transporter |